{"denomUnitsSelected":"Participants","reportingStatus":"NOT_POSTED","timeFrame":"Approximately 5 assessments will be performed between first dose of IMCgp100 and end of treatment, assessed up to 5.5 years.","title":"Pharmacokinetics: Frequency of Anti-IMCgp100 Antibody Formation","type":"SECONDARY"}